Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000215535 | SCV000270598 | likely benign | not specified | 2014-12-19 | criteria provided, single submitter | clinical testing | NEB exons 82-105 are organized in three repetitive blocks of 8 exons each and be cause these blocks are nearly identical in sequence, homologous exons (e.g., exo ns 86, 94, and 102) are co-amplified and sequenced (each amplicon consists of 6 alleles). This variant represents a nonhomologous position within the three repe titive blocks (c.13105C, c.14563T, and c.16021T) and is categorized as "Likely B enign" as all three positions code for an Leucine (p.Leu4369, p.Leu4855, p.Leu53 41). |
Prevention |
RCV000215535 | SCV000307206 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001833184 | SCV005813743 | benign | Nemaline myopathy 2 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001833184 | SCV002077028 | likely benign | Nemaline myopathy 2 | 2021-02-26 | no assertion criteria provided | clinical testing |